Biogen Inc (NASDAQ:BIIB)

Biogen Inc (NASDAQ:BIIB)


Share Price
$ 229.11
Change
-5.93 (-2.52 %)
Market Cap
$44,422.92 m
Proactive Investors - Run By Investors For Investors

Biogen Inc

Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing, and commercialization of innovative therapies. Patients in more than 90 countries benefit from Biogen Idec's significant products that address diseases such as lymphoma, multiple sclerosis, and rheumatoid arthritis.

EPIC: BIIB
Market: NASDAQ:BIIB
52-week High/Low: $388.67 / $216.13
Sector: Pharmaceuticals
Market Cap: $44,422.92 m
Website: www.biogenidec.com
col 3
col 4
col 5
col 6

Biogen Inc Timeline

Market Reports Including BIIB

VIEW ALL
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use